17 Results

People

  1. D'Andrea-Carlino
    D'Andrea-Carlino
  2. Hudis
    Hudis
  3. Norton
    Norton
  4. Seidman
    Seidman
  5. Panageas
    Panageas
  6. Fornier
    Fornier
  7. Lake
    Lake
  8. Dickler
    Dickler
  9. Moynahan
    Moynahan
  10. Gilewski
    Gilewski

Groups

  1. Breast Medicine Service (17)
  2. Department of Medicine (17)
  3. Epidemiology and Biostatistics (17)
  4. Solid Tumor Oncology Division (17)
  5. Survivorship Research (17)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  7. Biostatistics Service (15)
  8. Population Sciences Research Program (14)
  9. Behavioral Sciences Service (7)
  10. Psychiatry and Behavioral Sciences, Department of (7)
  1. "middle aged"
  2. "Epidemiology and Biostatistics"
  3. "Gabriella D'Andrea-Carlino"
Formats
  1. Journal Article (17)
Groups
  1. Breast Medicine Service (17)
  2. Department of Medicine (17)
  3. Epidemiology and Biostatistics (17)
  4. Solid Tumor Oncology Division (17)
  5. Survivorship Research (17)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)

More Groups

People
  1. Gabriella D'Andrea-Carlino (17)
  2. Clifford Hudis (16)
  3. Larry Norton (15)
  4. Andrew Seidman (12)
  5. Katherine Panageas (11)
  6. Diana Lake (10)

More People

Years
  1. 2015 (1)
  2. 2012 (1)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (2)
  6. 2008 (3)

More Years

Publications
  1. Clinical Cancer Research (6)
  2. Journal of Clinical Oncology (4)
  3. Breast Cancer Research and Treatment (3)
  4. Clinical Breast Cancer (3)
  5. Journal of Cancer Research and Clinical Oncology (1)
Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (4)
  3. Springer (4)
  4. Elsevier Inc. (3)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
    Journal Article

    Gajria, D.; Gonzalez, J.; Feigin, K.; Patil, S.; Chen, C.; Theodoulou, M.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab
    Journal Article

    Modi, S.; Stopeck, A.; Linden, H.; Solit, D.; Chandarlapaty, S.; Rosen, N.; D'Andrea, G.; Dickler, M.; Moynahan, M. E.; Sugarman, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
    Journal Article

    Sugarman, S.; Wasserheit, C.; Hodgman, E.; Coglianese, M.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2009)

    Fulltext@MSK | Save
  • A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: Immunological effects
    Journal Article

    Deng, G.; Lin, H.; Seidman, A.; Fornier, M.; D'Andrea, G.; Wesa, K.; Yeung, S.; Cunningham Rundles, S.; Vickers, A. J.; Cassileth, B.
    Journal of Cancer Research and Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Increased dose density is feasible: A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C.; Panageas, K. S.; Atienza, M.; Norton, L.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save